“Volatile” Asian markets drive Aceto’s Q4 growth
US fine and industrial chemicals specialist Aceto says that its expansion on the global stage, particularly in Europe and Asia, is starting to pay financial dividends.
Archives for September 7, 2008
Patheon slashes losses in Q3
Canada’s Patheon put in another quarter of robust revenues growth in its third quarter, which coupled with cost-reduction measures helped the firm trim its net loss to $14.7m, down 75 per cent on a year ago.
Bids imminent for Elan's contract division
The second round of bids for Elan Drug Technologies (EDT) is expected to be received by mid-September, with a sale price of up to $1.4bn mooted in press reports.
Tocris launches Target Detective
Tocris Bioscience has launched a new search facility that enables researchers to search for chemicals by the biological targets they work on, rather than the chemical name itself.
New investment to help Quotient grow even faster
UK analytical services expert, Quotient Bioscience has received a significant equity investment from TA Associates to help further the firm’s acquisition-led and organic growth strategy.
ReInnervate the difference for stem cells
UK researchers have developed two synthetic molecules that coax stem cells to differentiate into either neurons or epithelial cells for use in drug discovery applications.
Pharma outsourcing: people on the move
Outsourcing-Pharma.com presents its periodic round-up of executive appointments in the contract services sector.
Pharma manufacturing: People on the move
in-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical sector.
Bee Alert: new threat to US honeybees identified
US scientists have discovered a new threat to the US honeybee population using technology developed for detecting viruses on the battlefield.
Drugmakers within EC's REACH, says SAFC
Despite a decade-long build up, drugmakers are yet to wake up to the “no data, no market” mantra of the EC’s REACH legislation, according to SAFC’s marketing director Amanda Halford.